Showing 1,681 - 1,700 results of 4,739 for search '"malignancy"', query time: 0.07s Refine Results
  1. 1681

    Systematic Characterization of Splicing Dysregulation in Pan Solid Tumor Transcriptome by Jingru Sui, Dan Guo, Xiao Wen, Lei Zhou, Yue Huang, Haoyu Yu, Jinyu Chen, Zhaoqi Liu

    Published 2025-01-01
    “…Abstract Splicing dysregulation arising from spliceosomal mutations contributes to disease progression and treatment resistance, mostly in hematologic malignancy. Whereas spliceosomal mutations are less common in solid tumors, splicing disorders are pervasive and proven to promote tumorigenesis. …”
    Get full text
    Article
  2. 1682

    Metastatic Infiltrating Ductal Carcinoma of the Breast to the Colon: A Case Report and Literature Review by Salih Samo, Muhammed Sherid, Husein Husein, Samian Sulaiman, Jeffrey V. Brower, Seth Alper, Margaret Yungbluth, John A. Vainder

    Published 2013-01-01
    “…Colonic metastases occur most commonly secondary to peritoneal metastases from intra-abdominal malignancies. Breast cancer is the most common malignancy that metastasizes hematogenously to the colon. …”
    Get full text
    Article
  3. 1683

    Evaluation of antifungal effect of amphotericin B in comparison with nystatin on Candida species derived from patients undergoing head-and-neck radiotherapy

    Published 2024-12-01
    “…Background: There is ample evidence showing the development of nystatin-resistant strains in patients undergoing malignancy treatment. Amphotericin B is a polyene antifungal drug that combines with ergosterol to cause cell death and is more effective on fungal species than routine antifungals such as nystatin. …”
    Get full text
    Article
  4. 1684

    The Initial Experience of Trans-Rectal Ultrasound and Biopsy in Diagnosis of Carcinoma Prostate In Gezira Hospital For Renal Disease And Surgery (GHRDS) by Walaa Eldin Ibraheem, Sami Mahjoub Taha, Mustafa Omran Mansour, Mohammed El Imam Mohamed Ahmed

    Published 2017-05-01
    “…Transrectal U/S findings well correlated to the histopathological results, where abnormal findings (like hypo-echoic lesions or calcifications and cysts) showed higher incidence of malignancy in 46 patients constitute 52.8% of the abnormal U/S findings. …”
    Get full text
    Article
  5. 1685

    The Effects of Forodesine in Murine and Human Multiple Myeloma Cells by Liesbeth Bieghs, Jo Caers, Elke De Bruyne, Els Van Valckenborgh, Fiona Higginbotham, Karin Vanderkerken, Eline Menu

    Published 2010-01-01
    “…Multiple myeloma (MM) is the second most commonly diagnosed hematological malignancy, characterized by a monoclonal proliferation of malignant cells in the bone marrow. …”
    Get full text
    Article
  6. 1686

    Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma by Hong Yan, Nan Jiang, Xiaoying Li, Chenyang Lin, Fang Wang, Juan Zhang, Lijuan Chen, Dan Li

    Published 2025-01-01
    “…Multiple Myeloma (MM) is the second most common malignancy of the hematopoietic system, accounting for approximately 10% of all hematological malignancies, and currently, there is no complete cure. …”
    Get full text
    Article
  7. 1687

    Clinical utility of smartphone-based digital infrared thermal imaging in predicting vascular compromise in free flaps by Padmalakshmi Bharathi Mohan, S. Dineshkumar, Devi Prasad Mohapatra, Prasanth Penumadu, M.T. Friji, Ravi Kumar Chittoria

    Published 2024-01-01
    “…Eleven patients of microvascular-free flap reconstruction for defects following malignancy and trauma were included in the study for January 25, 2019–March 25, 2021. …”
    Get full text
    Article
  8. 1688

    Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer by Emre Ozoran, Fadime Didem Can Trabulus, Duygu Erhan, Bahadir Batar, Mehmet Guven

    Published 2022-01-01
    “…Breast cancer is the most common malignancy in women. Genetic risk factors associated with breast cancer incidence have been identified. …”
    Get full text
    Article
  9. 1689
  10. 1690

    A novel scoring system proposal to guide treatment of dogs with hepatoid gland tumors by Lorella Maniscalco, Matteo Olimpo, Lorenza Parisi, Paolo Buracco, Eugenio Mazzone, Greta Martinelli, Marina Martano, Selina Iussich, Emanuela Morello

    Published 2025-02-01
    “…The prognosis for dogs with perianal tumors depends largely on histology (benign vs. malignant) and, in case of malignancy, it has been suggested that the stage of the disease is important, with a more favorable outcome in dogs having small (under 5 cm in diameter), non-metastatic adenocarcinomas which are surgically removed with non-infiltrated margins. …”
    Get full text
    Article
  11. 1691

    Oncocytic Adrenocortical Neoplasm Diagnosed after Robot-Assisted Adrenalectomy by Andrew C. Harbin, Andrew Chen, Siddharth Bhattacharyya, Jasvir S. Khurana, Joshua R. Kaplan, Daniel D. Eun

    Published 2015-01-01
    “…Treatment is generally surgical, since OAN can be malignant in some cases. Differentiation between benign and malignant OAN is done based on the Lin-Weiss-Bisceglia criteria and can be difficult. …”
    Get full text
    Article
  12. 1692

    Unveiling the omics tapestry of B-acute lymphoblastic leukemia: bridging genomics, metabolomics, and immunomics by Yin Le, Shicong Zhu, Hongling Peng, Zhihua Wang

    Published 2025-01-01
    “…Abstract Acute B-lymphoblastic leukemia (B-ALL) is a highly heterogeneous hematologic malignancy, characterized by significant molecular differences among patients as the disease progresses. …”
    Get full text
    Article
  13. 1693

    Breast cancer classification based on hybrid CNN with LSTM model by Mourad Kaddes, Yasser M. Ayid, Ahmed M. Elshewey, Yasser Fouad

    Published 2025-02-01
    “…CNNs extract mammographic features, including spatial hierarchies and malignancy patterns, whereas LSTM networks characterize sequential dependencies and temporal interactions. …”
    Get full text
    Article
  14. 1694

    Aggressive Papillary Thyroid Carcinoma Presenting with Metastasis to the Pancreas by Firas Warda, Sam Ho, Enoch Kuo, Dinesh Rao, Marilu Jurado-Flores

    Published 2022-01-01
    “…Intra-abdominal metastasis from a thyroid malignancy source is quite rare and can be challenging as far as diagnosis and treatment. …”
    Get full text
    Article
  15. 1695
  16. 1696

    Factors Leading To Early Versus Late Presentation In Patients With Neck Masses by Ansa Umara Akram, Sadia Chaudhry, Nighat Qamar, Amna Kausar, Amna Javaid, Adia Bushra Piracha

    Published 2023-12-01
    “…In the majority of patients, the size of mass more than 1.5 cm (51.56%) revealed malignancy, while only a small percentage of patients (48.44%) had less than 1.5 cm neck mass. …”
    Get full text
    Article
  17. 1697

    Machine learning-assisted cancer diagnosis in patients with paraneoplastic autoantibodies by Alireza Maleki, Mohammad Mahdi Mirza Ali Mohammadi, Shahab Gholizadeh, Behnaz Dalvandi, Mohammad Rahimi, Aidin Tarokhian

    Published 2025-01-01
    “…Abstract Purpose Paraneoplastic syndromes (PNS) are a group of rare disorders triggered by an immune response to malignancy, characterized by diverse neurological, muscular, and systemic symptoms. …”
    Get full text
    Article
  18. 1698

    Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma by Kristian Larson, Hani M. Babiker, Andrew Kovoor, Joy Liau, Jordan Eldersveld, Emad Elquza

    Published 2018-01-01
    “…The low prevalence rate and limited literature on eccrine carcinoma (EC) pose a challenge to properly diagnosing and treating this rare malignancy. EC lesions tend to present similarly to other cutaneous neoplasms and dermatitis-like conditions. …”
    Get full text
    Article
  19. 1699

    A Case of Adenosarcoma of the Uterus by Shigeki Taga, Mari Sawada, Aya Nagai, Dan Yamamoto, Ryoji Hayase

    Published 2014-01-01
    “…Adenosarcoma is a rare tumor which consists of benign glandular epithelium and malignant mesenchymal component. Here we report a case of adenosarcoma of the uterine corpus. …”
    Get full text
    Article
  20. 1700

    Risk Factors and Predictive Model for Disseminated Intravascular Coagulation in Patients with Multiple Myeloma by Rong Bao MM, Mengtong Fan MM, Min Hu MM, Ling Li BD,   Hasichaolu BD

    Published 2025-02-01
    “…Objectives Multiple myeloma (MM) is a hematologic malignancy comprising approximately 10% of all blood cancers. …”
    Get full text
    Article